SCHEDULE: Vanguard Boosts Phreesia Stake to 9.52%

Sentiment:

Beneficial Ownership Report


The Vanguard Group has reported an increased beneficial ownership of 9.52% in Phreesia Inc., holding 5,704,786 shares of common stock.

Summary

  • The Vanguard Group, an investment adviser, has filed an Amendment No. 3 to Schedule 13G for Phreesia Inc.
  • Vanguard beneficially owns 5,704,786 shares of Phreesia Inc. Common Stock.
  • This represents 9.52% of the class of securities.
  • Vanguard holds sole dispositive power over 5,246,543 shares and shared dispositive power over 458,243 shares.
  • Shared voting power is held over 386,223 shares, with no sole voting power.
  • The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 7

Explanation: The filing indicates a significant passive institutional investment by The Vanguard Group in Phreesia Inc., which is generally viewed positively as a vote of confidence in the company's long-term prospects by a major asset manager.

Positives

  • The Vanguard Group, a major institutional investor, holds a significant 9.52% stake in Phreesia Inc., indicating institutional confidence.
  • The investment is stated to be for ordinary course of business, suggesting a passive, long-term holding strategy.

Negatives

  • No negative information regarding Phreesia Inc. or its operations is disclosed in this beneficial ownership report.

Risks

  • No specific company-related risks are detailed in this beneficial ownership filing.

Future Outlook

This filing, a beneficial ownership report from an institutional investor, does not contain any forward-looking statements or guidance from Phreesia Inc. or The Vanguard Group regarding future performance or strategic direction.

Management Comments

  • The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

The filing reflects a routine disclosure by a major asset manager, The Vanguard Group, regarding its passive investment in Phreesia Inc. Such significant institutional holdings are common across publicly traded companies, particularly in the healthcare technology sector, indicating ongoing investor interest in the industry.

Comparison to Industry Standards

  • The 9.52% stake held by The Vanguard Group is a substantial passive institutional investment, typical for large index fund managers.
  • This level of ownership is consistent with the investment strategies of major asset management firms like BlackRock or State Street, which often hold significant, non-controlling stakes across a broad portfolio of public companies.
  • No specific comparable companies or projects are mentioned in the filing to allow for a direct performance comparison.

Stakeholder Impact

  • Shareholders: May view the significant institutional ownership by Vanguard as a positive signal of stability and long-term confidence in Phreesia Inc.
  • Investment Community: The disclosure provides transparency regarding a major institutional investor's stake, which can influence market perception.

Next Steps

  • No specific future actions, events, or milestones are mentioned in this beneficial ownership filing.

Key Dates

DateDescription
09/30/2025Date of event requiring the filing of this statement.
10/30/2025Date of signature for the filing.

Recommendation

hold

The filing confirms a substantial passive investment by a leading institutional investor, The Vanguard Group, in Phreesia Inc. While this signals institutional confidence and can be a positive indicator, the Schedule 13G itself does not provide new operational or financial performance data to justify a 'buy' or 'sell' recommendation. It primarily serves as a disclosure of ownership, suggesting a 'hold' for existing investors who may interpret this as a positive long-term signal.

Keywords

Phreesia Inc, Vanguard Group, Institutional Investment, Beneficial Ownership, Schedule 13G, Common Stock, Healthcare Technology, Asset Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.